We are live on
!
Find out more
NVPX
Norwest Venture Partners XI Portfolio holdings
AUM
$32.1M
1-Year Est. Return
15.68%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+15.68%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
–
Cap. Flow
+$97.7M
Cap. Flow
% of AUM
95.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Health Catalyst
HCAT
|
+$97.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Health Catalyst
HCAT
$154M
| $102M | 100% |
+2,952,091
| New | +$97.7M |
|
Similar funds
AI
MCG
M
CCCPI
CRM
MTB
RA
SC
Norwest Venture Partners XI's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Norwest Venture Partners XI, which disclosed 1 position worth $102M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Health Catalyst: 2,952,091 shares worth $102M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Norwest Venture Partners XI's largest Q4 2019 buy was Health Catalyst: 2,952,091 shares worth $102M.
- Norwest Venture Partners XI's ten largest holdings make up 100% of its $102M portfolio in Q4 2019.
- Norwest Venture Partners XI disclosed 1 position in Q4 2019, its first 13F filing on record.
Based on Norwest Venture Partners XI's 13F filing for Q4 2019, filed 4 Feb 2020.